Angiopathy and retinal degeneration, dry macular degeneration, glaucoma, cataract

Course description
for the treatment of angiopathy, glaucoma, cataracts
The isolated peptides prevent the development of retinal degeneration, normalize metabolism and prevent the development of retinal degeneration and optic nerve atrophy.
*In case of wet macular degeneration, edema, hemorrhages in the retina, only Visoluten and Retisil can be used. In retinal sclerosis (fibrosis), the use of retinal peptides is contraindicated.
First month
for the treatment of angiopathy, glaucoma, cataracts
for the treatment of angiopathy, glaucoma, cataracts
82.00 €
| Revilab ML 03 | Prevent optic nerve atrophy |
Second month
for the treatment of angiopathy, glaucoma, cataracts
for the treatment of angiopathy, glaucoma, cataracts
336.00 €
| Visoluten №60 | Prevent the development of the retinal degeneration |
| Ventfort №60 | Normalizes the condition of the vascular wall |
| Cerluten №60 | Prevent the development of the retinal degeneration |
Third month
for the treatment of angiopathy, glaucoma, cataracts
for the treatment of angiopathy, glaucoma, cataracts
336.00 €
| Visoluten №60 | Prevent the development of the retinal degeneration |
| Ventfort №60 | Normalizes the condition of the vascular wall |
| Cerluten №60 | Prevent the development of the retinal degeneration |
Fourth month
for the treatment of angiopathy, glaucoma, cataracts
for the treatment of angiopathy, glaucoma, cataracts
32.00 €
| Revilab SL 02 | It normalizes vascular permeability; reduces the appearance of local inflammatory reaction; stimulates repair processes in diseases and injuries of the retina. |
Whole course
for the treatment of angiopathy, glaucoma, cataracts
for the treatment of angiopathy, glaucoma, cataracts
786.00 €
| Visoluten №60 | Prevent the development of the retinal degeneration |
| Ventfort №60 | Normalizes the condition of the vascular wall |
| Revilab SL 02 | It normalizes vascular permeability; reduces the appearance of local inflammatory reaction; stimulates repair processes in diseases and injuries of the retina. |
| Revilab ML 03 | Prevent optic nerve atrophy |
| Cerluten №60 | Prevent the development of the retinal degeneration |
| Title | Quantity | Directions for use | Mechanism of action | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||